Status:
UNKNOWN
The Relationship Between Anxiety, Depression and Stent Restenosis After Percutaneous Coronary Intervention
Lead Sponsor:
The First Hospital of Qinhuangdao
Conditions:
Coronary Heart Disease
Percutaneous Coronary Intervention
Eligibility:
All Genders
55-75 years
Brief Summary
Percutaneous coronary intervention is currently one of the effective methods for the treatment of ACS. Unfortunately, the incidence of ISR is as high as 10%-20% at 3-6 months after PCI. So it is neces...
Detailed Description
Percutaneous coronary intervention is currently one of the effective methods for the treatment of ACS. Unfortunately, postoperative in-stent restenosis (ISR) is still inevitable. The incidence of ISR ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of acute coronary syndrome The degree of coronary artery stenosis is greater than 90% The degree of coronary artery stenosis is greater than 75% and there is evidence of ischemia
Exclusion
- Patients who did not receive stents for the first time Patients who had undergone coronary artery bypass grafting Patients with stent implantation due to stent stenosis Patients who had stents implanted for chronic complete coronary artery occlusion Patients with malignant tumors Patients with autoimmune diseases Patients with severe hepatic and renal insufficiency Patients with cardiomyopathy Patients with congenital heart disease Patients with valvular disease Patients present with acute stress events
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04811976
Start Date
December 1 2019
End Date
March 31 2022
Last Update
March 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
中国
Qinhuangdao, Hebei, China, 066000